 - Patient must have adequate hepatic function as defined by 1 a serum bilirubin the institutional upper limit of normal IULN, and 2 SGOT or SGPT 2.5 x the institutional upper limit of normal obtained within 14 days prior to start of therapy. Liver function tests should be evaluated prior to each treatment. 